New York City, New York Aug 20, 2024 (Issuewire.com) - Dr. Stewart W. Comer, holds the role of Senior Director of Clinical Pathology at Illumina, Inc., a global leader in biotechnology and genomic sequencing. With his extensive background in molecular pathology and clinical diagnostics, he plays a critical role in advancing Illuminas mission to provide high-quality laboratory diagnostic services to improve patient care across a broad spectrum of health conditions, including infectious diseases, oncology, and prenatal genomic applications.
Dr. Comer earned his Medical Degree from the University of California San Diego School of Medicine and completed his internship and residency at the Naval Medical Center San Diego. He then completed his fellowship in molecular genetic pathology at the prestigious Memorial Sloan Kettering Cancer Center, and obtained his Master of Arts Degree in Business Management from the Peter F. Drucker School of Management at Claremont Graduate University.
Dr. Comer, who joined Illumina, Inc. in early 2022, brings over a decade of experience in pathology and laboratory medicine. Before his tenure at Illumina, he served at Mission Pathology Consultants, Inc. in Santa Barbara, where he was instrumental in providing diagnostic services and held leadership positions at multiple hospitals, including Goleta Valley Cottage Hospital and Santa Barbara Cottage Hospital. His extensive leadership experience includes serving as the Chair of Pathology and Laboratory Medicine and Laboratory Director for several prominent healthcare organizations in the region.
Board-certified in anatomic and clinical pathology by the American Board of Pathology (ABPath), Dr. Comer is dedicated to setting high certification standards and promoting lifelong competency within the field. He is a Fellow of the College of American Pathologists and holds a Certificate of Qualification from the New York State Department of Health for Molecular Genetics and Oncology Testing. Furthermore, he is an active member of several professional organizations, including the Association for Molecular Pathology and the American Statistical Association.
Dr. Comers leadership at Illumina, Inc. will be pivotal in enhancing the laboratorys capabilities in complex genetic and genomic testing, ultimately contributing to improved patient outcomes and advancements in therapeutic care.
Learn More about Dr. Stewart W. Comer:
Through his findatopdoc profile, https://www.findatopdoc.com/doctor/1546923-Stewart-Comer-Pathologist or through Illumina, Inc. https://www.illumina.com/
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey toward optimal health by providing you with the know-how to make informed decisions for you and your family.
Source :Stewart W. Comer, MA, MD, FACP
This article was originally published by IssueWire. Read the original article here.